Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 neoadjuvant trial comparing ARX788 plus pyrotinib to trastuzumab plus pertuzumab with docetaxel and carboplatin in HER2-po…
-
FDA approval · 2024-10-29FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Nexus Pharmaceuticals, LLC)
FDA approved Nexus Pharmaceuticals, LLC to market a generic cyclophosphamide product under Original Application ANDA216783.
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Project Breast47: Effect of an Educational Intervention [NA]
This update notes completion of Project Breast47, a University of Oviedo trial assessing the effect of an educational intervention on breast…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI
This clinical trial is recruiting to evaluate rapid histologic assessment of stereotactic breast biopsy using miniature mass spectrometry an…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: ARX788 in HER2-positive Metastatic Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial of ARX-788 for HER2-positive metastatic breast cancer is described, currently not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study [NA]
A randomized controlled study at Baskent University evaluating digital technology–assisted education for patients undergoing breast reconstr…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
Results from a trial evaluating limited heart monitoring during non-anthracycline trastuzumab-based therapy in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors [Phase 1]
A Phase I trial evaluating CCT303-406 in relapsed or refractory HER2-positive solid tumors is active but not recruiting, including gastric c…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of LY3022855 In Participants With Breast or Prostate Cancer [Phase 1]
This Phase 1 study of LY3022855 in breast and prostate cancer has completed, with results posted on 2024-10-28.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Functional Precision Oncology for Metastatic Breast Cancer [NA]
This clinical trial update notes the completion of a study on functional precision oncology for metastatic breast cancer in HER2-negative di…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer [NA]
The study evaluates large segmentation radiotherapy with or without Deep Inspiration Breath Hold (DIBH) for left breast cancer and is curren…
-
EMA withdrawal · 2024-10-24EMA Withdrawn: Onbevzi (bevacizumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn the marketing authorization for Onbevzi (bevacizumab) by Samsung Bioepis NL B.V., across multiple cancer indications. …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel) [Phase 2]
Phase 2 clinical trial evaluating ribociclib in combination with an aromatase inhibitor versus physician’s choice of chemotherapy sequential…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial [Phase 2]
Phase 2 trial update evaluating the effect of vaginal estrogen on serum estradiol in breast cancer patients receiving aromatase inhibitors f…
-
FDA approval · 2024-10-23FDA Approved: JYLAMVO — Supplemental Application (SHORLA ONCOLOGY INC.)
The FDA approved a supplemental application for JYLAMVO (methotrexate) filed by SHORLA ONCOLOGY INC.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating a two-week dosing regimen of vinorelbine with liposomal doxorubicin for HER2-negative metastatic breast cancer; t…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer [NA]
A completed clinical trial investigated pre-operative cryoablation with immune therapy for early-stage breast cancer; results have been post…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer [NA]
A clinical trial evaluating one week versus three weeks of adjuvant radiotherapy in breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer [NA]
A clinical trial registration for evaluating intelligent vacuum-assisted biopsy before surgery as a surrogate for chemotherapy response in b…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial [Phase 2]
A Phase 2 trial (MIMOSA) evaluating Monalizumab in combination with Trastuzumab for metastatic HER2-positive breast cancer has completed enr…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer [Phase 1]
This Phase 1 trial evaluated M7824 (bintrafusp alfa) in patients with stage II-III HER2-positive breast cancer and various AJCC stage groupi…
-
CLINICAL_TRIALS withdrawal · 2024-10-22Clinical Trial Update: A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care [Phase 2]
Phase 2 feasibility and acceptability pilot trial evaluating a patient-specific targeted intervention using patient navigators versus routin…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video [NA]
This video update discusses efforts to improve uptake of genetic cancer risk assessment among African American women in relation to breast c…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating Sacituzumab Govitecan-hziy versus physician's choice in HR+/HER2- metastatic breast cancer completed; results have …
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Quilting Sutures After Mastectomy [NA]
A clinical trial update notes ongoing recruitment for a study on quilting sutures after mastectomy in breast cancer patients.